Diffusion-weighted imaging to predict longer-term response in Crohn's disease patients commencing biological therapy: results from the MOTILITY trial.
Hameed M. et al, (2025), The British journal of radiology, 98, 527 - 534
Small Bowel Motility Quantified by Cine MRI to Predict Longer-Term Response in Patients with Crohn's Disease Commencing Biological Therapy: The Motility Study.
Plumb AA. et al, (2025), Inflamm Bowel Dis
MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's disease.
Sakai NS. et al, (2025), Insights into imaging, 16
Navigating Chronic Pouchitis: Pathogenesis, Diagnosis, and Management.
Hill R. et al, (2025), Gastroenterology & hepatology, 21, 46 - 58
Hypercoagulation after Hospital Discharge in Acute Severe Ulcerative Colitis: A Prospective Study
Griffiths BJ. et al, (2024), Clinical Gastroenterology and Hepatology
The Urgency Numeric Rating Scale: Psychometric Evaluation in Adults with Crohn's Disease.
Dubinsky M. et al, (2024), Advances in therapy
Gaps in acute upper GI bleed (AUGIB) endoscopy training: a UK trainees and trainers’ survey
Nigam GB. et al, (2024), Frontline Gastroenterology
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease
Thomas T. et al, (2024), Nature Immunology, 25, 2152 - 2165
Value of Engagement in Digital Health Technology Research: Evidence Across 6 Unique Cohort Studies.
Goodday SM. et al, (2024), Journal of medical Internet research, 26
Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial
de Cates AN. et al, (2024), The British Journal of Psychiatry, 1 - 8
Neutralizing Autoantibodies against Interleukin-10 in Inflammatory Bowel Disease.
Griffin H. et al, (2024), The New England journal of medicine, 391, 434 - 441
Mucosal Healing with Vedolizumab in Patients with Chronic Pouchitis: EARNEST, a Randomized, Double-Blind, Placebo-Controlled Trial.
Jairath V. et al, (2024), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn's Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study.
Schreiber S. et al, (2024), Digestive diseases and sciences
Patient interpretations of patient-reported outcome measures to assess bowel urgency: qualitative interviews in ulcerative colitis.
Jairath V. et al, (2024), Journal of patient-reported outcomes, 8
Exclusive Enteral Nutrition Mediates Beneficial Gut Microbiome Enrichment in Acute Severe Colitis.
Bajaj A. et al, (2024), Inflammatory bowel diseases, 30, 641 - 650
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial.
Lindsay JO. et al, (2024), The lancet. Gastroenterology & hepatology, 9, 333 - 345
Study protocol for a Randomised controlled trial of EArly transjugular intrahepatiC porTosystemic stent-shunt in Acute Variceal Bleeding (REACT-AVB trial).
Tripathi D. et al, (2024), BMJ open gastroenterology, 11
Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trial.
Jairath V. et al, (2024), BMJ open gastroenterology, 11